These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 19729434)

  • 41. Genetics of diabetic nephropathy: lessons from mice.
    Breyer MD; Tchekneva E; Qi Z; Takahashi T; Fogo AB; Zhao HJ; Harris RC
    Semin Nephrol; 2007 Mar; 27(2):237-47. PubMed ID: 17418691
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alterations of urinary metabolite profile in model diabetic nephropathy.
    Stec DF; Wang S; Stothers C; Avance J; Denson D; Harris R; Voziyan P
    Biochem Biophys Res Commun; 2015 Jan; 456(2):610-4. PubMed ID: 25499815
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isolating and Culturing Mouse Podocyte Cells to Study Diabetic Nephropathy.
    Vasilopoulou E
    Methods Mol Biol; 2020; 2067():53-59. PubMed ID: 31701445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Imaging mass spectrometry reveals direct albumin fragmentation within the diabetic kidney.
    Grove KJ; Lareau NM; Voziyan PA; Zeng F; Harris RC; Hudson BG; Caprioli RM
    Kidney Int; 2018 Aug; 94(2):292-302. PubMed ID: 29779708
    [TBL] [Abstract][Full Text] [Related]  

  • 45. eNOS knockout mice with advanced diabetic nephropathy have less benefit from renin-angiotensin blockade than from aldosterone receptor antagonists.
    Kosugi T; Heinig M; Nakayama T; Matsuo S; Nakagawa T
    Am J Pathol; 2010 Feb; 176(2):619-29. PubMed ID: 20042665
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bradykinin B2 receptors--a target in diabetic nephropathy.
    Doggrell SA
    Expert Opin Ther Targets; 2005 Apr; 9(2):411-4. PubMed ID: 15934924
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of calmodulin in pancreatic beta cells induces diabetic nephropathy.
    Yuzawa Y; Niki I; Kosugi T; Maruyama S; Yoshida F; Takeda M; Tagawa Y; Kaneko Y; Kimura T; Kato N; Yamamoto J; Sato W; Nakagawa T; Matsuo S
    J Am Soc Nephrol; 2008 Sep; 19(9):1701-11. PubMed ID: 18525005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A model for diabetic nephropathy: advantages of the inducible cAMP early repressor transgenic mouse over the streptozotocin-induced diabetic mouse.
    Inada A; Kanamori H; Arai H; Akashi T; Araki M; Weir GC; Fukatsu A
    J Cell Physiol; 2008 May; 215(2):383-91. PubMed ID: 18270980
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism.
    Zanchi A; Moczulski DK; Hanna LS; Wantman M; Warram JH; Krolewski AS
    Kidney Int; 2000 Feb; 57(2):405-13. PubMed ID: 10652017
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, in diabetic eNOS knockout mice.
    Kosugi T; Heinig M; Nakayama T; Connor T; Yuzawa Y; Li Q; Hauswirth WW; Grant MB; Croker BP; Campbell-Thompson M; Zhang L; Atkinson MA; Segal MS; Nakagawa T
    Am J Pathol; 2009 Apr; 174(4):1221-9. PubMed ID: 19246639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A severe diabetic nephropathy model with early development of nodule-like lesions induced by megsin overexpression in RAGE/iNOS transgenic mice.
    Inagi R; Yamamoto Y; Nangaku M; Usuda N; Okamato H; Kurokawa K; van Ypersele de Strihou C; Yamamoto H; Miyata T
    Diabetes; 2006 Feb; 55(2):356-66. PubMed ID: 16443768
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diabetic nephropathy: molecular analysis of extracellular matrix and clinical studies update.
    Striker GE; Eastman RD; Striker LJ
    Nephrol Dial Transplant; 1996; 11 Suppl 5():58-61. PubMed ID: 9044309
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors.
    Sugimoto H; Grahovac G; Zeisberg M; Kalluri R
    Diabetes; 2007 Jul; 56(7):1825-33. PubMed ID: 17456853
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined inhibition of CCR2 and ACE provides added protection against progression of diabetic nephropathy in
    Tesch GH; Pullen N; Jesson MI; Schlerman FJ; Nikolic-Paterson DJ
    Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1439-F1449. PubMed ID: 31566438
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fatty acid binding protein 3 as a potential mediator for diabetic nephropathy in eNOS deficient mouse.
    Ozawa S; Ueda S; Li Y; Mori K; Asanuma K; Yanagita M; Nakagawa T
    Biochem Biophys Res Commun; 2014 Nov; 454(4):531-6. PubMed ID: 25450688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pathogenesis of diabetic nephropathy: focus on microRNAs and proteomics.
    Conserva F; Pontrelli P; Accetturo M; Gesualdo L
    J Nephrol; 2013; 26(5):811-20. PubMed ID: 23543479
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of nitric oxide in diabetic nephropathy.
    Prabhakar SS
    Semin Nephrol; 2004 Jul; 24(4):333-44. PubMed ID: 15252773
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammation and the pathogenesis of diabetic nephropathy.
    Wada J; Makino H
    Clin Sci (Lond); 2013 Feb; 124(3):139-52. PubMed ID: 23075333
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synergistic contributions of carbonyl stress and megsin in diabetic nephropathy.
    Inagi R; Nangaku M; Miyata T
    Ann N Y Acad Sci; 2005 Jun; 1043():605-8. PubMed ID: 16037283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ADMA elevation does not exacerbate development of diabetic nephropathy in mice with streptozotocin-induced diabetes mellitus.
    Rodionov RN; Jarzebska N; Schneider A; Rexin A; Sradnick J; Brilloff S; Martens-Lobenhoffer J; Bode-Böger SM; Todorov V; Hugo C; Weiss N; Hohenstein B
    Atheroscler Suppl; 2019 Dec; 40():100-105. PubMed ID: 31818438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.